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Abstract
It is generally accepted that, in vertebrates, omega-3 (n-3) and omega-6 (n-6) poly-unsaturated fatty acids (PUFA) compete
for D-6 desaturase enzyme in order to be bioconverted into long-chain PUFA (LC-PUFA). However, recent studies into
teleost fatty acid metabolism suggest that these metabolic processes may not conform entirely to what has been previously
observed in mammals and other animal models. Recent work on rainbow trout has led us to question specifically if linoleic
acid (LA, 18:2n-6) and a-linolenic acid (ALA, 18:3n-3) (D-6 desaturase substrates) are in direct competition for access to D-6
desaturase. Two experimental diets were formulated with fixed levels of ALA, while LA levels were varied (high and low) to
examine if increased availability of LA would result in decreased bioconversion of ALA to its LC-PUFA products through
substrate competition. No significant difference in ALA metabolism towards n-3 LC-PUFA was exhibited between diets while
significant differences were observed in LA metabolism towards n-6 LC-PUFA. These results are evidence for minor if any
competition between substrates for D-6 desaturase, suggesting that, paradoxically, the activity of D-6 desaturase on n-3 and
n-6 substrates is independent. These results call for a paradigm shift in the way we approach teleost fatty acid metabolism.
The findings are also important with regard to diet formulation in the aquaculture industry as they indicate that there
should be no concern for possible substrate competition between 18:3n-3 and 18:2n-6, when aiming at increased n-3 LC-
PUFA bioconversion in vivo.
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Introduction
Due to economic and environmental concerns shaping the
rapidly expanding aquaculture sector, marine fish oil in fish feed
(aquafeed) formulations is being increasingly reduced and
substituted with alternative oils of terrestrial origin, such as
vegetable oils and animal fats [1–3]. The direct result of this shift
in feed formulation is that present aquafeeds contain progressively
lesser long chain polyunsaturated fatty acids of the omega-3 series
(n-3 LC-PUFA), which are known to deliver health benefits to
humans consuming seafood [4–6]. Ultimately, this results in
a detrimental modification of the final content of these health-
promoting fatty acids in the flesh of cultured fish [7,8]. In an
attempt to overcome this problem, the understanding of the in vivo
n-3 LC-PUFA biosynthetic capability of fish is attracting
significant research effort, and it is envisaged that increased
knowledge in this area will contribute towards the long term
sustainability of the entire fisheries and aquaculture sector [9].
In all vertebrates, the in vivo n-3 LC-PUFA biosynthetic
pathway is conceptually identical [10,11], and involves a series
of enzymatic steps catalysed by two fatty acid desaturase enzymes
(D-6 desaturase and D-5 desaturase), two fatty acid elongase
enzymes (Elovl-5 and Elovl-2) and a peroxisomal b-oxidation for
fatty acid chain shortening [12,13]. This pathway, commonly
referred to as the ‘‘Sprecher pathway’’, can convert the two
essential polyunsaturated fatty acids (PUFA) linoleic acid (LA,
18:2n-6) and a-linolenic acid (ALA, 18:3n-3) into n-6 LC-PUFA
(such as arachidonic acid, ARA 20:4n-6), and n-3 LC-PUFA (such
as eicosapentaenoic acid, EPA 20:5n-3, and docosahexaenoic acid,
DHA 22:6n-3), respectively. Because of evolution and adaptation
to the environment, each species has a different capacity for
bioconversion of PUFA into LC-PUFA, depending on the
presence, abundance and activity of the specific enzymes in the
metabolic pathway [11,14–16]. For example, it can be argued that
the ability of biosynthesising n-3 LC-PUFA is greater in fish
compared to birds, and greater in birds compared to humans,
further emphasizing the importance of aquaculture as a provider
of nutritional n-3 LC-PUFA [4,15,17,18]. Recently, variants in the
fatty acid desaturase gene cluster that result in different enzyme
efficiencies and adaptive evolution have been documented in
humans [19]. Similarly, differences in the efficiency of this
metabolic activity amongst closely related species have been
reported. For example, within teleosts there are species such as
salmonids that are capable of bioconverting n-3 LC-PUFA, and
other species such as several top-order marine predators that seem
to have lost this capability [11].
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Much of our knowledge of in vivo fatty acid metabolism
originates from studies on mammals (primarily rodents), but in
recent years many advances have been made in understanding
fatty acid metabolism in fish, and some peculiarities have been
reported [20–23]. However, some of the paradigms proposed for
mammals are also valid for fish. Of high relevance are the early
pioneering studies on LA and ALA bioconversion in rats by
Holman’s group [24,25], which led to the acceptance that the
same enzymes are involved in the biosynthesis of n-3 and n-6
PUFA, respectively. This was confirmed by a series of later studies
[26,27] and led to the well-accepted paradigm that the two
substrates (LA and ALA) are in direct competition for accessing D-
6 desaturase (the first of the bioconverting enzymes). However, in
a recent review of the fatty acid D-6 desaturase in teleosts [28], it
was reported that the data on D-6 desaturase substrate competition
in appear to be somewhat contrasting, and the authors urged
further investigation to better identify these mechanisms.
Rainbow trout (Oncorhynchus mykiss) are one of the most
commonly cultured salmonids, and their farming is responsible
for a large use of fish oil [29]. Thus, finding possible remedial
strategies towards minimising the use of this commodity, while at
the same time maintaining optimal nutritional quality of the final
product, is a highly relevant and timely objective [9]. We have
recently shown the following in trout: i) they are capable of
efficiently bioconverting ALA up to EPA and DHA [18]; ii) the
elimination of dietary n-3 LC-PUFA (enzyme products) up-
regulates the transcription rate of D-6 desaturase mRNA; however,
the total apparent in vivo enzyme activity does not correlate with D-
6 desaturase mRNA expression [30]; iii) that the LC-PUFA
biosynthetic pathway is substrate limited [31]; and iv) that the
provision of increased dietary stearidonic acid (18:4n-3), over
ALA, has only minimal benefit in terms of total n-3 LC-PUFA
biosynthesis, suggesting that D-6 desaturase cannot be considered
as the rate-limiting step in this pathway [32].
Thus, in light of the differences reported in the fatty acid
bioconversion metabolism of teleosts compared to that of
mammals, the aim of this study was to directly assess if the
commonly accepted paradigm that the two substrates (LA and
ALA) are in direct competition for accessing D-6 desaturase was
valid for fish as it is in mammals. To achieve this, two triplicate
groups of rainbow trout were fed two experimental diets
characterised by identical dietary ALA but different LA content.
The in vivo fatty acid metabolism, and in particular, the bio-
conversion of ALA towards n-3 LC-PUFA was then assessed. The
results from this study are envisaged to be also directly relevant for
the aquaculture industry; a variety of alternative oils, with different
levels of LA content, can be used in feed formulation, but the
possible resultant impact on in vivo n-3 LC-PUFA biosynthesis (and
thus the final n-3 LC-PUFA content of cultured products) has not
yet been established.
Materials and Methods
Ethics Statement
All animals and procedures used in this experimentation were
approved by the Deakin University Animal Welfare Committee
Table 1. Formulation and proximate composition of the
experimental diets.
Experimental Diets1
LLA HLA
Diet formulation (g/kg)
Basal Diet2 842.8 842.8
Linseed oil 78.6 78.6
High Oleic acid Sunflower oil 78.6 –
Traditional Sunflower oil – 78.6
Proximate composition (mg/g)
Moisture 61.6 56.0
Protein 407.2 414.7
Lipid 192.5 194.9
Ash 73.6 73.6
NFE3 265.0 260.8
Energy (MJ/Kg)4 21.8 22.0
1Experimental diets abbreviations: LLA Low Linoleic Acid diet; HLA – High
Linoleic Acid diet.
2Basal diet composition (g/kg): fish meal 129.4; poultry by-product meal 318.5;
soybean protein concentrate 124.4; blood meal 24.9; pre-gelatinised starch
209.0; mineral and vitamin mix 8; amino acid mix (methionine, lysine, aspartic
acid and glutamic acid) 23.6; CeliteH 5.
3Nitrogen free extracts calculated by difference.
4Calculated on the basis of 23.6, 39.5 and 17.2 kJ/g of protein, fat and
carbohydrate, respectively.
doi:10.1371/journal.pone.0057463.t001
Table 2. Growth and feed utilization parameters, biometrical
data and apparent digestibility coefficients of rainbow trout
fed the experimental diet for 88 days.
Experimental treatments1
LLA HLA P-value
Growth and feed utilization
Initial weight (g) 13.460.8 13.660.3 ns
Final weight (g) 206.766.5 193.9610.3 ns
Total feed consumption
(g/fish)
226.369.0 228.4610.3 ns
SGR2 3.160.0 3.060.1 ns
FCR3 1.160.0 1.260.1 ns
Biometrical parameters
DP%4 82.8660.07 83.0161.11 ns
HSI%5 1.8160.06 1.7760.02 ns
K6 1.6860.04 1.6660.01 ns
Nutrients digestibility (%)
ADC7 (Dry matter) 80.560.7 82.761.3 ns
ADC (Lipid) 94.860.3 94.960.4 ns
ADC (Protein) 88.360.2 90.060.8 ns
Fatty acid digestibility (%)
ADC (18:1n-9) 96.3460.42 95.9960.25 ns
ADC (18:2n-6) 97.4660.21 97.5060.15 ns
ADC (18:3n-3) 98.2160.18 98.0360.14 ns
Data are expressed as mean 6 s.e.m., n =3; N = 6. P-value: ns=not significant;
*, ** and *** indicate P,0.05, ,0.01 and ,0.001, respectively.
1See table 1 for experimental diets abbreviation.
2SGR = Specific Growth Rate.
3FCR= Food conversion ratio.
4DP%= dress-out percentage.
5HSI%= hepatosomatic index.
6Fulton’s condition factor.
7ADC=Apparent Digestibility Coefficients.
doi:10.1371/journal.pone.0057463.t002
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(A99-2010). All possible steps towards minimizing animal suffering
were taken.
Animals, Experimental Design and Sampling
Rainbow trout (Oncorhynchus mykiss) sourced from the De-
partment of Primary Industries, Snob’s Creek hatchery (Victoria,
Australia), were transported to Deakin University’s Aquaculture
Research Facility at the Warrnambool campus. Prior to the
commencement of the experiment, fish were acclimatised to the
experimental conditions for 2 weeks and maintained on a com-
mercial trout diet (Skretting, Cambridge, Tasmania, Australia)
ration at 2% of their body weight daily. The experiment was
Table 3. The fatty acid composition (mg/g lipid) of experimental diet, initial fish fillets and rainbow trout fillet fed the experimental
diets for 88 days.
Experimental diets1 Experimental treatments1
LLA HLA Initial LLA HLA P-value
14:0 4.9 4.8 20.0 7.360.2 6.960.3
14:1n-5 0.5 0.4 – – –
15:0 0.7 0.6 2.3 0.460.2 0.160.1
16:0 95.2 104.3 171.8 114.161.6 114.561.0
16:1n-7 16.9 16.4 35.1 27.261.2 22.262.1
18:0 42.0 43.7 48.6 38.760.4 40.660.8
18:1n-9 466.3 255.8 173.7 387.665.2 225.563.7 ***
18:1n-7 10.1 10.5 23.3 12.860.2 11.660.3 *
18:2n-6 105.1 307.6 56.5 70.961.2 196.163.9 ***
18:3n-6 0.4 0.2 1.1 2.060.1 4.360.4 **
18:3n-3 196.1 198.0 10.4 96.862.0 95.762.8
18:4n-3 0.9 0.7 4.8 12.060.1 11.060.7
20:0 2.1 2.0 1.0 1.560.0 1.660.1
20:1n-11 0.7 0.7 – 0.060.0 0.060.0
20:1n-9 3.4 2.6 7.9 10.560.2 7.260.1 ***
20:2n-6 0.4 0.4 3.3 3.460.1 9.360.3 ***
20:3n-6 – – 3.1 3.660.1 8.360.6 **
20:4n-6 1.8 1.8 11.5 3.760.1 6.160.2 ***
20:3n-3 – – – 4.460.1 4.460.2
20:4n-3 0.6 0.5 9.2 6.160.3 5.860.6
20:5n-3 7.0 6.2 57.9 9.760.6 8.760.1
22:0 2.1 2.0 1.0 1.560.0 1.560.1
22:1n-11 – – 2.5 0.460.2 0.260.2
22:1n-9 0.7 0.8 1.0 1.460.0 0.860.1 **
22:2n-6 – – 1.0 0.560.2 1.460.1 *
22:4n-6 0.4 0.5 4.1 0.860.2 1.360.1
22:3n-3 0.8 0.6 2.4 0.860.3 2.060.7
22:5n-3 1.5 1.5 22.1 4.060.1 3.760.0
22:6n-3 7.2 6.9 197.3 37.861.6 41.462.4
Total Fatty acids2 967.4 969.2 872.8 859.6611.9 832.365.8
SFA 146.9 157.4 244.6 163.562.2 165.461.3
MUFA 498.5 287.2 243.5 439.866.4 267.566.3 ***
PUFA 322.1 524.6 384.7 256.364.7 399.5610.5 ***
n-6 PUFA 108.1 310.2 80.7 84.761.5 226.864.6 ***
n-6 LC-PUFA 2.6 2.6 23.0 11.860.7 26.461.0 ***
n-3 PUFA 214.0 214.4 304.1 171.663.1 172.766.0
n-3 LC-PUFA 17.1 15.7 288.9 62.862.1 66.063.7
Data are expressed as mean 6 s.e.m., n = 3; N = 6. P-value: ns=not significant; *, ** and *** indicate P,0.05, ,0.01 and ,0.001, respectively (diets and initial fish not
included in the statistical test).
1See table 1 for experimental diets and treatments abbreviation.
2Fatty acid class abbreviations: SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; LC-PUFA, long chain polyunsaturated
fatty acids (,20 carbon atoms); n-6: omega-6 fatty acids; n-3: omega-3 fatty acids.
doi:10.1371/journal.pone.0057463.t003
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conducted in a closed loop, thermostatically and photoperiod-
controlled recirculating aquaculture system (RAS). The system
consisted of 18 (1000 L) rearing tanks (only 6 were used in the
present study), with biological and physical filtration (drum filter
with 60-mm screen; Hydrotech,Vellinge, Sweden), in-line oxygen
enrichment and ultra violet (UV) disinfection. The system was
maintained on a 12:12 hour light:dark cycle. Temperature
(15.061uC) and dissolved oxygen (9.16.3 mg/L) were maintained
at optimal conditions. The levels of metabolic waste, total
ammonium and nitrite, were monitored bi-weekly using Aqua-
merck test kits (Merck, Darmstadt, Germany), and they remained
below 0.50 and 0.05 mg L21, respectively, for the duration of the
trial.
Two iso-proteic and iso-lipidic experimental diets were formu-
lated to contain 200 mg/g of lipid and 400 mg/g of protein,
varying only in lipid source (Table 1). Three lipid sources (linseed
oil, traditional sunflower oil and high oleic sunflower oil) were used
and blended to obtain two experimental diets characterised by an
abundant ALA content and identical overall fatty acid composi-
tion, with the exception of LA and oleic acid (OA, 18:1n-9). The
two experimental diets were named high linoleic acid diet (HLA)
and low linoleic acid diet (LLA), and the only expected difference
in their fatty acid composition was the relative content of these two
fatty acids. The experimental diets were manufactured and stored
as previously described [33].
Following an acclimation period, an initial sample of 10 fish
(initial sample) were euthanized in excess anaesthetic (AQUI-S,
0.5 ml L21) and stored at 220uC until subsequent analysis. 120
fish (mean weight 13.560.1 g) were randomly distributed into 6
tanks (20 fish per tank). Each of the tanks was then randomly
assigned one of the two dietary treatments in triplicate (3 tanks per
treatment; n=3, N=6). Fish were fed with one of the two
experimental diets twice daily to apparent satiation at 0900 and
1600 h for an 88 day grow-out period. Feed consumption and
mortalities were recorded throughout the duration of the trial.
Faeces were collected from day 63 to 88, for subsequent
digestibility estimation. At the completion of the grow-out phase,
all fish were anesthetized and weighed, and 33 fish from each
treatment (11 fish per tank) were randomly selected, euthanized in
excess anaesthetic and stored at 220uC until subsequent analysis.
The 11 sampled fish from each replicate (tank) were randomly split
into 3 groups: the first group (4 fish) was used for biometry; the
second group (4 fish) was used for chemical analysis of the whole
body; and the third group (3 fish) was used for chemical analysis of
Figure 1. Differential gene expression of fatty acid D-6 desaturase and elongase in liver of rainbow trout fed the two different
experimental diets. Data presented as mean 6 s.e.m. (n=3; N= 6). No statistically significant differences were observed.
doi:10.1371/journal.pone.0057463.g001
Table 4. The apparent in vivo enzymatic activities (nmol/g/
day), including de novo production, b-oxidation, desaturation
and elongation of total fatty acids grouped per main classes,
in rainbow trout fillet fed the experimental diets for 88 days
and deduced by the whole body fatty acid balance method.
Experimental diets1 P-Value
LLA HLA
SFA and MUFA2
De novo production 520678 1496135 ns
Total elongation 666676 2026142 *
Total b-oxidation 1,1616199 1,2136514 ns
Total D-9 desaturation 269617 93660 *
n-6 PUFA
Total elongation 52614 134611 *
Total b-oxidation 513621 2,1016345 *
Total D-6 desaturation 54615 175611 **
Total D-5 desaturation 565 4165 **
n-3 PUFA
Total elongation 904632 775669 ns
Total b-oxidation 1,047680 1,4406247 ns
Total D-6 desaturation 718622 668660 ns
Total D-5 desaturation 256610 220630 ns
Data are expressed as mean 6 s.e.m., n = 3; N = 6. P-value: ns=not significant;
*, ** and *** indicate P,0.05, ,0.01 and ,0.001, respectively.
1See table 1 for experimental diets and treatments abbreviation.
2See table 3 for fatty acid classes abbreviations. 2Fatty acid classes
abbreviations: SFA: saturated fatty acids; MUFA: monounsaturated fatty acids;
n-6 PUFA: omega-6 polyunsaturated fatty acids; n-3 PUFA: omega-3
polyunsaturated fatty acids.
doi:10.1371/journal.pone.0057463.t004
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fillet and liver. From this last group, an aliquot of,150 mg of liver
tissue was taken immediately and snap frozen by immersion in
liquid nitrogen for subsequent RNA isolation.
Chemical Analyses, Nutrient Digestibility and Growth
Performances
The chemical composition of the experimental diets, faeces and
fish samples was determined via proximate composition analysis
according to standard methods, as previously described [34].
Briefly, moisture was determined by drying samples in an oven at
80uC to a constant weight. Ash was determined by incinerating
samples in a muffle furnace (Wit, C & L Tetlow, Australia) at
550uC for 18 h. Protein (Kjeldahl nitrogen: N66.25) content was
determined using an automated Kjeltech 2300 (Foss Tecator,
Geneva, Switzerland). Lipid was determined using a cold extrac-
tion technique of Folch, et al., [35] as modified by Ways and
Hanahan [36], with the only modification that dichloromethane
was used to replace chloroform for safety reasons. Following lipid
extraction, fatty acids were esterified into methyl esters using an
acid-catalysed methylation method and then analysed by gas
chromatography using an Agilent Technologies GC 7890A
(Agilent Technologies, Santa Clara, California, USA) and
published methods [37].
Faeces were collected for the evaluation of digestibility as
previously described [34], and digestibility was determined by
assessing acid insoluble ash (AIA), as specifically adapted to
rainbow trout and previously described [38].
Standard formulae were used to assess growth, feed utilisation
and other relevant parameters; these included initial and final
average weight, total feed consumption, specific growth rate
(SGR), food conversion ratio (FCR), dress-out percentage (DP%),
hepatosomatic index (HSI%) and condition factor (K).
Fatty Acid Metabolism, RNA Isolation and Gene
Expression
The estimation of the apparent in vivo fatty acid metabolism was
computed using the whole-body fatty acid balance method, as
initially proposed and described by Turchini et al., [39] with
further development [18,40].
Total RNA was extracted from approximately 10 mg of liver
tissues using TRI-reagent (Sigma) followed by phase separation
with chloroform then precipitation with isopropanol. The RNA
concentration and purity was determined using a Nanodrop 1000
spectrophotometer (Thermo Scientific). One mg of RNA was
treated with DNAse 1 (Invitrogen) prior to reverse transcription
using Superscript III Reverse Transcriptase (Invitrogen), accord-
ing to manufacturer’s protocol. The synthesized first-strand cDNA
(40 mL) was diluted to 80 mL using nuclease-free water and stored
at 220uC. The expression of fatty acid D-6 desaturase and fatty
acid elongase (Elovl5) mRNA was determined by semi-quantita-
tive real-time PCR (qPCR). qPCR was performed in duplicate
using a Rotor Gene RG 3000 (Corbett Research) in a 25 mL
reaction containing 2 mL of diluted cDNA, the primer pair
(100 nM of forward and reverse) and 12.5 mL of SYBRH Premix
Ex TaqTM (Takara Bio) and a two-step reaction profile (94uC for 5
Figure 2. The apparent in vivo fate of 18:2n-6 or 18:3n-3 towards direct elongation to 20:2n-6 or 20:3n-3, D-6 desaturation to 18:3n-
6 or 18:4n-3, b-oxidation or deposition as is, expressed as percentage of dietary net intake, in rainbow trout fed the two
experimental diets (LLA and HLA) and deduced by the whole-body fatty acid balance method. (A) in vivo fate of 18:2n-6 in trout fed LLA;
(B) in vivo fate of 18:2n-6 in trout fed HLA; (C) in vivo fate of 18:3n-3 in trout fed LLA; (D) in vivo fate of 18:3n-3 in trout fed HLA. In each graph, data
represent mean values (n =3; N =6), and the only statistically significant difference recorded was for the percentage of 18:3n-3 directly elongated to
18:4n-3 in trout fed LLA or HLA (*P,0.05).
doi:10.1371/journal.pone.0057463.g002
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seconds, 60uC for 20 seconds). A melting curve analysis was
performed at the end of 40 cycles to determine the specificity of
the reaction. The mRNA expression was normalized by the ratio
of the threshold cycle (Ct) value to the concentration of the single
stranded cDNA and is given by 2-DDCt. The concentration of
single-stranded cDNA was quantified against oligonucleotide
standards in an assay using a Quant-iT OliGreen ssDNA reagent
and kit (Invitrogen). Specific primer pairs were designed for
rainbow trout based on the gene sequences available in GenBank
(http://www.ncbi.nlm.nih.gov): D-6 desaturase (accession no.
NM001124287) forward; 59-ACCTAGTGGCTCCTCTGGTC-
39, reverse; 59-CAGATCCCCTGACTTCTTCA-39) and elon-
gase 5 (accession no. AY605100) forward; 59- TCAA-
CATCTGGTGGTTCGTCAT-39, reverse; 59- TGTTCAGG-
GAGGCACCAAAG-39) using Primer Express (ver. 3, Applied
Biosystems). Amplification of the correct cDNA was confirmed by
sequencing.
Statistical Analysis
All data were reported as mean 6 standard error (N=3, N=6).
After confirmation of normality and homogeneity of variance,
data was subjected to an independent T-test. Significance was
accepted at P,0.05, and P values were reported as * P,0.05, **
P,0.01 and *** P,0.001. All statistical analyses were performed
using SPSS v17.0 (SPSS Inc., Chicago, IL, USA).
Results
During the 88 day feeding trial, no mortality was recorded. Fish
grew up to over 15-fold their initial body weight, and no
statistically significant differences were recorded for any of the
growth and feed utilisation parameters, biometrical data or
nutrient digestibility (Table 2).
The fatty acid composition of the two experimental diets and of
the trout fillets at the start and end of the feeding trial is presented
in Table 3. The two diets had an almost identical overall fatty
acid composition, with the only difference being relative to their
respective content of 18:1n-9 and 18:2n-6; the LLA diet contained
466.3 and 105.1 (mg/g lipid) and the HLA diet contained 255.8
and 307.6 (mg/g lipid) of the two fatty acids, respectively. At the
end of the feeding trial, the trout fillet showed statistically
significant differences for the content of MUFA and n-6 PUFA
(particularly 18:1n-9, 18:1n-7, 18:2n-6, 18:3n-6, 20:1n-9, 20:2n-6,
20:3n-6, 20:4n-6, 22:1n-9 and 22:2n-6), but there were no
differences found for any of the n-3 PUFA.
In trout liver, the transcription rates of fatty acid D-6 desaturase
and fatty acid elongase were not affected by the dietary treatment
(Figure 1). The overall apparent in vivo fatty acid enzymatic
activities are reported in Table 4, with significant differences
found for elongation, desaturation (D-6 and D-5) and b-oxidation
of n-6 PUFA, and elongation and D-9 desaturation of SFA and
MUFA. No significant differences were recorded for any
enzymatic activities on n-3 PUFA or for b-oxidation of SFA and
MUFA.
The metabolic fate of 18:2n-6 or 18:3n-3 towards direct
elongation, D-6 desaturation, b-oxidation or direct deposition
(expressed as percentage of dietary net intake) in trout fed the two
experimental diets is reported in Figure 2. For both treatments,
the majority of both dietary 18:2n-6 and 18:3n-3 was directly
deposited (from 43.3 to 65%), and a relatively large amount was b-
oxidised (from 31.2 to 41.7%). Only about 3.3% of 18:2n-6 was D-
6 desaturated, whilst up to 15% of dietary 18:3n-3 was D-6
desaturated. The only statistically significant difference recorded
was for the direct elongation of 18:3n-3 towards the production of
20:3n-3, which was significantly higher in LLA compared to HLA.
In rainbow trout fed the two experimental diets (LLA and
HLA), the apparent in vivo bioconversion activities (nmol/g/day)
for all the individual steps along the fatty acid bioconversion
pathway, and deduced by the whole-body fatty acid balance
method, are reported in Figure 3. With regards to the availability
of the two initial fatty acid substrates (dietary net intake of 18:2n-6
and 18:3n-3), a large and statistically significant difference was
recorded for 18:2n-6, whilst no difference was recorded for 18:3n-
3 (Figure 3A). A statistically significant higher elongation of
18:3n-3 toward the production of 20:3n-3 was recorded in LLA
fed fish, compared to HLA fed fish (Figure 3B), whilst no
statistically significant differences were recorded for any bio-
conversion step of 18:3n-3 towards the final production of 22:6n-3
(Figures 3D–H). On the other hand, for the n-6 PUFA series,
statistically significant differences were recorded for the D-6
desaturation of 18:2n-6 towards the production of 18:3n-6
(Figure 3D), the elongation of 18:3n-6 towards the production
of 20:3n-6 (Figure 3E) and the D-5 desaturation of 20:3n-6
towards the production of 20:4n-6 (Figure 3D).
Discussion
The two experimental diets were formulated to provide optimal
nutrition for trout, differing only in their fatty acid composition. In
the present trial, we have shown that fish fed either experimental
diets showed optimal growth performances, and no effects of the
diet were observed on growth performances, feed utilisation
parameters, biometric data and nutrient digestibility, which is
largely consistent with several previous studies [3].
As is well-documented, the fatty acid composition of fish tissues
is reflective of that present in their diet [1–3,7]. In this study, it was
shown that the fillet of fish fed LLA (containing higher amounts of
18:1n-9) recorded a higher level of 18:1n-9 in the fillet, and also
other fatty acids directly derived from the in vivo bioconversion of
this fatty acid, such as 20:1n-9 and 22:1n-9. In addition, the fillet
of fish fed HLA (containing higher amounts of 18:2n-6) recorded
a higher level of 18:2n-6, and also other fatty acids directly derived
from the in vivo bioconversion of this fatty acid, such as 18:3n-6,
20:2n-6, 20:3n-6 and 20:4n-6. These observations clearly suggest
that the dietary fatty acid composition is critical in determining the
fatty acid composition of fish tissues, and that in vivo fatty acid
metabolism can have a measurable effect.
The specific objective of this study was to assess the possible
existence of substrate competition for the D-6 desaturase enzyme.
Previously, it has been documented that the transcription rates of
genes encoding the enzymes involved in the LC-PUFA bio-
synthetic pathway can be affected by the presence or absence of
Figure 3. The apparent in vivo 18:2n-6 and 18:3n-3 bioconversion activity (nmol/g/day) in rainbow trout fed the two experimental
diets (LLA and HLA) and deduced by the whole-body fatty acid balance method. Graphs are reported following the PUFA bioconversion
pathway, from (A) substrate availability (dietary net intake); towards i) the dead end pathway (on the left): (B) elongation of 18:2n-6 and 18:3n-3; (C)
elongation of 20:2n-6 and 20:3n-3; and ii) the LC-PUFA biosynthetic pathway(on the right): (D) D-6 desaturation of 18:2n-6 and 18:3n-3; (E) Elongation
of 18:3n-6 and 18:4n-3; (F) D-5 desaturation of 20:3n-6 and 20:4n-3; (G) Elongation of 20:4n-6 and 20:5n-3; (G) Elongation, D-6 desaturation and chain
shortening of 22:4n-6 and 22:5n-3. In each graph, bars represent mean 6 s.e.m., n =3; N = 6. P-value: ns=not significant; *, ** and *** indicate
P,0.05, ,0.01 and ,0.001, respectively.
doi:10.1371/journal.pone.0057463.g003
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dietary LC-PUFA [11,28,30]. However, in the present study, both
experimental diets contained identical concentrations of LC-
PUFA, and thus, similar genes transcription rates should have
been expected. Accordingly, there were no differences in the
hepatic fatty acid D-6 desaturase and fatty acid elongase mRNA
transcription rates between the two dietary treatments. This is an
important observation, as any possible difference in the apparent
in vivo enzymatic activity cannot be attributed to different gene
transcription rates.
In the present study, we have recorded significant effects of the
dietary treatment on the apparent in vivo bioconversion of MUFA
and n-6 PUFA, and this is consistent with a previous observation
that these metabolic pathways are substrate limited in teleosts [31].
Thus, fish fed the LLA diet (receiving more dietary 18:1n-9)
recorded an increased bioconversion of this fatty acid, whilst fish
fed the HLA diet (richer in 18:2n-6) recorded increased activities
in the various bioconversion steps of n-6 PUFA.
The most important finding of the present study was, that
independently from the availability of 18:2n-6, the bioconversion
of 18:3n-3 towards longer chain and more unsaturated fatty acid
was almost completely unaffected. The only observed significant
difference was for the amount of 18:3n-3 directly elongated
towards 20:3n-3 (commonly referred to as ‘‘the dead end
pathway’’), which was higher in fish fed the LLA. This clearly
supports the existence of a direct substrate competition between
18:2n-6 and 18:3n-3 for accessing the fatty acid elongase. On the
other hand, no differences were observed in the D-6 desaturation
of 18:3n-3, and also in any of the subsequent bioconversion steps
towards the final production of 22:6n-3.
As mentioned earlier, the paradigm that the two substrates
(18:2n-6 and 18:3n-3) are in direct competition for accessing D-6
desaturase, the first of the bioconverting enzymes for LC-PUFA
biosynthesis, has been well-documented and demonstrated for
mammals [24–27]; consequently, it has been accepted by the
scientific community. However, it has been previously suggested
that the fatty acid D-6 desaturase may behave quite differently in
teleosts [28]. The results of our study strongly suggest that in
rainbow trout there is no apparent competition between the two
substrates (18:2n-6 and 18:3n-3) for accessing D-6 desaturase.
Thus, a specific paradigm shift should be considered from ALA
and LA being in competition for accessing D-6 desaturase enzyme,
to ALA and LA being D-6 desaturated independently from the
presence and abundance of each other.
D-6 desaturase is known to be a single enzyme required twice
within the LC-PUFA biosynthetic pathway, and acting on both n-
6 and n-3 PUFA [10–13,28]. Accordingly, this metabolic pathway
has also been well-established for rainbow trout [41,42]. Neverthe-
less, the findings of our study have shown that substrate
competition is not a limiting factor for the activity of this enzyme,
and are in agreement with our previous observation that the
provision of increased dietary 18:4n-3 and 18:3n-6 did not permit
for increased activity on the 24:5n-3 substrate [32]. Therefore, as
reported in this study, ‘‘paradoxically, it appears that the activity of
the same enzyme on the different substrates is an independent
process’’.
Admittedly, even if no statistically significant differences were
recorded, when compared to fish fed LLA, fish fed the HLA diet
received a numerically higher amount of dietary 18:3n-3, and
recorded a numerically lower mean apparent in vivo bioconversion
activity on this fatty acid. This may suggest the existence of a minor
substrate competition, but this can only be considered as being
trivial as the actual in vivo n-3 LC-PUFA biosynthesis was
statistically unaffected by the amount of 18:2n-6 provided in the
diet. This trend was further observed in all 18:3n-3 derivatives
along the bioconversion pathway. Notably, the difference in
percentage of substrate desaturated at the final D-6 desaturation
step to 22:6n-3 did not increase as would have been expected
under the competing substrates paradigm. This lack of reduction
in production of 22:6n-3 as a result of increased LA further
strengthens the argument of no evident substrate competition
between n-3 and n-6 for access to D-6 desaturase in rainbow trout.
Conclusions
In the present study, we have shown that in rainbow trout there
is no evidence of substrate competition for accessing the fatty acid
D-6 desaturase. This finding is envisaged to be useful towards
increasing our understanding of fatty acid metabolism in teleosts,
which seems to be considerably different from that of mammals.
From a more practical point of view, this finding can also be
considered as being applicable in the aquaculture industry, since
when formulating aquafeed towards maximising the potential
in vivo n-3 LC-PUFA biosynthesis in cultured fish, priority should
be given to using alternative oils rich in 18:3n-3 irrespective of any
concern as to their 18:2n-6 content.
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